Adverse events associated with opioid-containing cough and cold medications in children.
Ian M PaulKate M ReynoldsJody L GreenPublished in: Clinical toxicology (Philadelphia, Pa.) (2018)
These safety surveillance data support the FDA's expanded label changes limiting opioid CCMs for children.